The 20th Regulatory Affairs and Pharmacovigilance conference of Medicines for Europe keeps on providing useful insights of the path ahead.

Digitalisation has been mentioned as one of the main pillars within the Pharmaceutical Strategy for Europe, being considered a key tool to easy the regulatory burden, facilitate the communication between all the stakeholders, and address particular needs of the regulatory landscape. The two most highlighted examples are the use of electronic product information and the simplification of regulatory procedures through digital platforms.

Our Asphalion experts Lidia Cánovas, General Manager, Regulatory Affairs and Eduardo Garrido, Medical Device Officer are attending the congress.

Next congress sessions are scheduled on the 2nd and 4th of February.

At Asphalion we will stay tuned to keep you updated on all forthcoming changes!

If you have any questions do not hesitate to contact us at: info@asphalion.com

Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Destacadas

Entrevista con Dámaso Molero, director ...

by 3P Biopharmaceuticals

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el d...

El consumo regular de sardinas tiene un ...

by Fundació Clínic per a la Recerca Biomèdica

Nutrientes presentes en la sardina en altas cantidades, como la taurin...

Diapositiva de Fotos